Detalhe da pesquisa
1.
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
Cell
; 146(5): 697-708, 2011 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21884932
2.
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Blood
; 135(7): 463-471, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841594
3.
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
N Engl J Med
; 378(25): 2386-2398, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860938
4.
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.
Blood
; 133(7): 676-687, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510081
5.
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia.
Cancer
; 126(6): 1264-1273, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860140
6.
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.
Cancer
; 125(4): 541-549, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30422308
7.
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.
Am J Hematol
; 93(2): 254-261, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29119643
8.
Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia.
Haematologica
; 102(4): 719-727, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28034990
9.
Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
Cancer
; 122(15): 2379-88, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27171984
10.
Health care utilization and end-of-life care for older patients with acute myeloid leukemia.
Cancer
; 121(16): 2840-8, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25926135
11.
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(5): 730-4, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24530972
12.
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
Br J Haematol
; 165(4): 497-503, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24528179
13.
Get out--and stay out.
Blood
; 119(17): 3869-70, 2012 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22538491
14.
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response.
Blood
; 120(23): 4649-52, 2012 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23074281
15.
Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults.
Am J Hematol
; 89(7): 698-705, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24668776
16.
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.
Nature
; 451(7176): 335-9, 2008 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18202658
17.
Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
Biol Blood Marrow Transplant
; 19(8): 1190-6, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23747459
18.
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
Biol Blood Marrow Transplant
; 19(6): 981-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562738
19.
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.
Blood
; 118(17): 4666-73, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873545
20.
Myelodysplastic syndromes: clinical practice guidelines in oncology.
J Natl Compr Canc Netw
; 11(7): 838-74, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847220